The importance of TGF-β signalling [149] and EMT [144] in bone metastasis and the role of the upregulated integrins in promoting tumour invasion and metastasis [137] suggests the associated signalling pathways as a therapeutic target in advanced prostate cancer. The gene discussed is TGFB1; the disease is Familial prostate cancer.